VICINIUM
TRIALS
Purpose
The purpose of this study is to determine the effectiveness
and safety of Vicinium in patients with non-invasive carcinoma
in situ (CIS) bladder cancer who have failed previous treatment
with Bacille Calmette-Guérin (BCG).
| Condition
|
Intervention |
Phase |
| Bladder Cancer (non-invasive) |
Drug: Vicinium |
Phase II |
Study Type: Interventional
Study Design: Non-Randomized,
Open Label, Efficacy & Tolerability Study
Official Title: A Phase II Study to Evaluate
the Efficacy and Tolerability of Intravesical Vicinium in
Patients with Non-Invasive Urothelial Carcinoma in Situ (CIS)
previously treated with Bacille Calmette-Guérin (BCG)
|
